Thomas Bieber

34PUBLICATIONS
115CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyCardiology (incl. cardiovascular diseases)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|May 21, 2026
Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.

|Oct 02, 2025
Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.

Gilles Tiraboschi, Kim Papp, Thomas Bieber

|Sep 23, 2025
Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?

Eric L Simpson, Jonathan I Silverberg, Bob Geng

|May 19, 2025
Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins.

Danielle Fehr, Van Hung Huynh-Tran, Laura Maintz

|Feb 18, 2025
Guideline-Directed Medical Therapy for Heart Failure in Transthyretin Amyloid Cardiomyopathy.

Stéphanie Kristina Schwarting, Thomas Bieber, Daniel R Davies

|Oct 04, 2024
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis.

José Miguel Alvarenga, Thomas Bieber, Tiago Torres

Pageof 6

Frequent Collaborators

7 joint publications

Laura Maintz

5 joint publications

Stephan Weidinger

4 joint publications

Emma Guttman-Yassky

4 joint publications

Claudia Traidl-Hoffmann